Answers are grounded in this paper and cite their sources.
Pancreatic cancer poses a grave prognosis due to the advanced and inoperable stage at which it is usually diagnosed and lack of effective therapy. Frondanol®-A5, produced from an edible sea cucumber inhibits growth of pancreatic cancer cells. In the present study, we examined the effects of a sub-fraction, Frondanol®-A5P on cell cycle and apoptosis. Cells were cultured in serum-free conditions 24 hours prior to treatment. Cell cycle and apoptosis-related proteins were evaluated by western blotting. Cells were stained with propidium iodide for cell cycle analysis. Messenger RNA was quantified by real-time RT-PCR. Frondanol®-A5P inhibited proliferation of pancreatic cancer cells by arrest in the G2/M phase of the cell cycle and induction of apoptosis. Thymidine incorporation was concentration-dependently decreased by Frondanol®-A5P and was markedly inhibited in AsPC-1 (P<0.005) and S2-013 (P<0.02), at 15.6 and 31.2 μg/ml, respectively. Marked cleavage of caspase 3 and PARP at 24 hours and increasing by 48 hours of treatment confirmed the induction of apoptosis. Western blots explained the G2/M phase arrest, with a decrease in cyclin A, cyclin B and CDC25c in treated cells versus controls at 24 hours. Frondanol®-A5 increased the apoptotic p21waf1 mRNA by 55-fold in AsPC-1 and 8-fold S2013 cells at three hours. The increase in p21waf1 protein was 6-fold in AsPC-1 cells and 11-fold in S2-013 cells at three hours, persisting beyond 24 hours. Frondanol®-A5P induced marked phosphorylation of p38 kinase within five minutes. Treating the cells simultaneously with the p38 kinase inhibitor, SB203580 markedly reduced the Frondanol®-A5P-induced expression of p21 waf1. Apoptosis induced by Frondanol®-A5P is associated with a marked increase in expression of the p-21 waf1 triggered via p38 kinase. It is likely that p21waf1 mediates the Frondanol®-A5P-induced cell cycle arrest. Since Frondanol®-A5P comes from as edible, nontoxic source, it may be valuable for therapy or prevention of pancreatic cancer.
No takes yet. Share an insight, caveat, or question.
Roginsky et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: